Similarly, in human epidermal growth factor (HER)-2 overexpressing SK-BR-3 breast cancer cells, leptin treatment increased proliferation between 5 and 50 ng/ml, but not at 100 ng/ml (11). Here, LEP is linked to breast carcinoma.